Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics

Active, not recruitingOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions
Coronary Artery Disease
Interventions
PROCEDURE

Cardiac PET, Coronary catheterization

"Patients would under go a Cardiac rest and stress PET scan and include the following drug administration:~1. N-13 Ammonia radionuclide - Two doses, 10 mCi for rest, 20 mCi for stress~2. Lexiscan - stress agent for PET scan~Patients would also undergo Coronary catheterization including the following drug administration and device usage:~1. Combowire to obtain pressure and flow readings on Combomap machine (Volcano Therapeutics, CA).~2. Adenosine - stress agent during catheterization, 140 ug/Kg/min"

Trial Locations (1)

45220

Cincinnati Veteran Affairs Medical Center, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER

NCT01719016 - Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics | Biotech Hunter | Biotech Hunter